Capital Fund Management (CFM)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-36,772
Closed -$9.03M – 1683
2022
Q3
$9.03M Buy
36,772
+141
+0.4% +$38.1K 0.07% 353
2022
Q2
$9.07M Buy
36,631
+12,100
+49% +$3.27M 0.08% 339
2022
Q1
$8.13M Buy
24,531
+7,810
+47% +$2.4M 0.07% 399
2021
Q4
$6.01M Buy
+16,721
New +$5.65M 0.04% 561
2020
Q4
– Sell
-22,937
Closed -$6.35M – 1625
2020
Q3
$6.35M Sell
22,937
-26,214
-53% -$7.55M 0.08% 288
2020
Q2
$11.9M Sell
49,151
-42,081
-46% -$8.45M 0.19% 155
2020
Q1
$13.2M Buy
91,232
+53,127
+139% +$8.82M 0.2% 147
2019
Q4
$6.5M Buy
+38,105
New +$7.06M 0.05% 454
2018
Q4
– Sell
-3,511
Closed -$1.22M – 2311
2018
Q3
$1.58M Sell
3,511
-15,047
-81% -$5.93M 0.01% 1209
2018
Q2
$7.59M Buy
+18,558
New +$6.72M 0.04% 569
2018
Q1
– Sell
-11,320
Closed -$2.87M – 2273
2017
Q4
$2.12M Sell
11,320
-6,815
-38% -$1.27M 0.01% 965
2017
Q3
$3.06M Sell
18,135
-25,172
-58% -$3.81M 0.02% 663
2017
Q2
$6.21M Sell
43,307
-24,124
-36% -$3.24M 0.05% 418
2017
Q1
$8.44M Sell
67,431
-47,599
-41% -$5.52M 0.07% 319
2016
Q4
$13M Buy
115,030
+50,713
+79% +$5.87M 0.11% 251
2016
Q3
$8.27M Buy
64,317
+49,663
+339% +$5.95M 0.08% 313
2016
Q2
$1.6M Buy
14,654
+9,059
+162% +$901K 0.02% 804
2016
Q1
$530K Sell
5,595
-141,310
-96% -$11.9M 0.01% 1115
2015
Q4
$13.3M Buy
+146,905
New +$12.5M 0.14% 202
2015
Q3
– Sell
-23,149
Closed -$1.52M – 1740
2015
Q2
$1.52M Buy
+23,149
New +$1.54M 0.02% 710
2014
Q3
– Sell
-24,400
Closed -$613K – 1897
2014
Q2
$613K Buy
+24,400
New +$568K 0.01% 1137

Other funds holding ABMD

Capital Fund Management (CFM)'s ABMD Position: Q4 2022 in Review

Capital Fund Management (CFM) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 36,772 shares — an estimated $9.03M sold.

Capital Fund Management (CFM) first reported a position in ABMD in Q2 2014 and held it in 21 quarters. The position peaked at $13.3M in Q4 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Capital Fund Management (CFM) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 36,772 Abiomed Inc shares in Q4 2022, an estimated $9.03M.
  • Capital Fund Management (CFM) first reported a position in Abiomed Inc in Q2 2014 and held it in 21 quarters.
  • Capital Fund Management (CFM)'s Abiomed Inc position peaked at $13.3M in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2022, filed 13 Feb 2023.